P13 Disease-Free Survival as a Potential Surrogate Endpoint for Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analyses

S Abogunrin,M Lorenzi,S Cadarette,R Belleli,L Polito,E Wissinger

doi:10.1016/j.jval.2022.09.025

P13 Disease-Free Survival as a Potential Surrogate Endpoint for Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analyses

S Abogunrin, M Lorenzi + Show 4 more

Open Access

https://doi.org/10.1016/j.jval.2022.09.025

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: Dec 1, 2022
License type: publisher-specific-oa

Affiliation: Roche (Switzerland)

#Surrogate Endpoint For Overall Survival #Early-Stage Non-Small Cell Lung Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

P13 Disease-Free Survival as a Potential Surrogate Endpoint for Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analyses

Full Text